U.S. flag

An official website of the United States government

Display Settings:

Format
Sort by

Send to:

Choose Destination

Links from Protein

Items: 4

1.
Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status
Lauren K. Shea, Kazuhito Honjo, David T. Redden, Edlue Tabengwa, Ran Li, Fu-Jun Li, Mikhail Shakhmatov, Nicholas Chiorazzi, Randall S. Davis
Blood Cancer J. 2019 Jun; 9(6): 47. Published online 2019 May 15. doi: 10.1038/s41408-019-0207-7
PMCID:
PMC6520396
ArticlePDF–537K
2.
FcR-Like 2 Inhibition of B Cell Receptor-Mediated Activation of B Cells
Tanisha A. Jackson, Christopher L. Haga, Götz R. A. Ehrhardt, Randall S. Davis, Max D. Cooper
J Immunol. Author manuscript; available in PMC 2017 Apr 5.
Published in final edited form as: J Immunol. 2010 Dec 15; 185(12): 7405–7412. Published online 2010 Nov 10. doi: 10.4049/jimmunol.1002305
PMCID:
PMC5381824
AbstractArticlePDF–1.0M
3.
Identification of a family of Fc receptor homologs with preferential B cell expression
Randall S. Davis, Yui-Hsi Wang, Hiromi Kubagawa, Max D. Cooper
Proc Natl Acad Sci U S A. 2001 Aug 14; 98(17): 9772–9777. Published online 2001 Aug 7. doi: 10.1073/pnas.171308498
PMCID:
PMC55528
AbstractArticlePDF–888K
4.
Biochemical and Functional Insights into the Integrated Regulation of Innate Immune Cell Responses by Teleost Leukocyte Immune-Type Receptors
Chenjie Fei, Joshua G. Pemberton, Dustin M. E. Lillico, Myron A. Zwozdesky, James L. Stafford
Biology (Basel) 2016 Mar; 5(1): 13. Published online 2016 Mar 8. doi: 10.3390/biology5010013
PMCID:
PMC4810170
AbstractArticlePDF–1.0M

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center